Which of the following leading pharmaceutical companies recently announced the receipt of World Health Organisation Prequalification of Medicines Programme (WHO PQ) approval for its generic version of COVID-19 oral anti-viral treatment candidate Nirmatrelvir?
1
Cipla
2
Laurus Labs
3
Hetero
4
Ajanta Pharma
5
Cadilla Healthcare